2017 | Northwestern University Pritzker School of Law, American Law | LL.M.
2012 | East China University of Political Science and Law, International Law | LL.M.
2011 | University of Warwick School of Law, International Economic Law| LL.M.
2006 | East China University of Political Science and Law, International Law | LL.B.
2008 Bar Admission, P. R. China
■ Cross-border and Outbound Investments:
Represented a renowned Chinese public pharmaceutical company in its acquisition of a major CDMO asset from a world leading pharmaceutical group headquartered in Switzerland.
Represented a renowned Chinese public pharmaceutical company in its acquisition of two CRO (Contracted Research Organization) entities in the United States.
Represented a public traded valve manufacturer in its acquisition of manufacturing assets in Germany and Canada; assist in the client’s global operations.
Advised a U.S. real estate fund on the solicitation of Chinese investors; assisted in the incorporation and capitalization of a U.S. building company with Chinese investments.
Advised a U.S. automotive client for the Chinese part of a global acquisition project; project managed due diligence and drafted DD report.
Advised a Hong Kong based client for its acquisition of an advertisement and design WOFE in Shanghai.
■ IT, Cloud Computing, Gaming
Advised a top global technology company on the entry of its IaaS cloud computing services and IDC infrastructure into China;
Advised a leading operating system corporation on the China legal issues relating to its cloud services for the industries of entertainment, financing and medical;
Advised a silicon start-up on its entry into the Shanghai Free Trade Zone.
Advised a U.K. mobile game company on its entry into China market.
Advised a sports game company on its licensing arrangement with China Soccer League and China Basketball Association.
Data Protection: Advised on data protection compliance matters to multi-national firm clients in the sectors from media, Internet, IT and semiconductor to fashion and luxury, finance, pharmaceutical and education; advising to China based multi-national client on GDPR related matters by collaborating with European lawyers.
■ Fashion & Luxury
Project managed the rolling out of the new China business model of a world major diamond and jewellery company; drafted/reviewed licenses, management agreements and cooperation agreements; led the negotiation of major contracts with governmental jewellery appraisal institutions, major national jewellery retailers and major national financing groups.
Advised a U.K. luxury brand on its licensing, manufacture and distribution in China.
Advised a top menswear brand on the transition of its China business from licensing to franchising.
Managed trademark and copyright portfolio for various fashion clients in China; monitored and handled hundreds of trademark registrations and copyright registrations; project managed a number of CTMO proceedings and trademark litigations.
Handled IP infringement matters for various fashion industry clients; project managed counterfeiting actions against more than dozens of infringers. Actions included sending cease and desist letter, collection and notarization of evidences, filing of government complaints and instituting criminal and civil litigations.
Advised a major French insurance group on the entry of its insurance intermediary business in China; advised in the subsequent acquisition deal and conducted legal audit on the target companies.
Advised a U.S. bank on its entry into China for on-line payment business.
Advised a Europe financial institution on the regulations relating to online banking, security and insurance in China.
■ Pharmaceutical & Medical Equipment:
Regulatory analysis for a major UK medicine company with respect to centralized medicine purchase and anti-trust issues; project managed the review of over one hundred tendering documents and contracts.
Project managed the establishment of a medical equipment JV; advised the JV on its patent and trademark strategy; project managed anti-counterfeit campaign for the JV in China.
Advised a world leading media group on the rolling out of its TV cooperation, IP licensing and theme park businesses in China; drafted/reviewed acquisition and licensing arrangements and documents.
Advised a format company on its regulatory issues arising from the latest legal development and advised on the available options.
Advised a U.K. filmmaking company on its Joint Venture with a Chinese media group.
Handled the negotiation between a U.K. magazine company and a China magazine under NDRC; reviewed deal structure and drafted deal documents.
Advised two major F&B franchisors from Singapore on their entries into the Chinese market; project managed the establishment of the franchise systems of the clients in China, including development of master franchisees and registration with MOFCOM.
Advised a major international franchise group on the strategy for the localization of its various brands in the China market and the restructuring of its established local franchise network.
Advised a top global real-estate brokerage group on the establishment of its franchise system in China.
Advised a major real-estate brokerage group on the liquidation and sale of its China franchise network. Advised various franchisor clients on their disputes with local franchisees.
Honors & Evaluation
Arthur has been practicing for more than a decade and has helped dozens of multi-national firms to expand their businesses to China, through the establishment of joint ventures, wholly owned foreign enterprises, franchising, or licensing opportunities.
Arthur provides comprehensive assistance on Chinese foreign direct investment laws and regulations, and analysis on investment structure, market entry and industry regulation, antitrust issues, foreign exchange regulations and corporate finance matters.
In parallel with servicing leading multinational firms, Arthur has successfully serviced many Chinese public companies in cross-border transactions and outbound direct investments. Arthur and his team support various Chinese private and public firms in their strategy to operate internationally. His Chinese clientele include well-known Internet, technology, pharmaceutical and manufacturing enterprises.
Supporting a wide range of prestigious luxury and fashion brands, as well as companies in the technology, media and telecommunications, and pharmaceutical and medical devices sectors, Arthur is extensively experienced in related legal matters and have good insights in the most cutting-edge development of the market, allowing him to provide legal solutions precisely satisfying clients’ commercial needs.
With legal education from law schools in Shanghai, England and the U.S., Arthur has obtained a strong global vision and the expertise of solving Chinese legal issues in an approach compatible with the needs of western clients.
Arthur contributed to the reports by Asia Cloud Computing Association with respect to the adoption and regulation of cloud in industries such as finance and healthcare, and the various issues regarding data protection and data sovereignty. His valuable insights in technology related legal issues is widely recognized by multinational technology and media clients.
Arthur also oversees and project manages many clients’ IP portfolio, licensing and franchising, infringement and counterfeit, and other intellectual property matters in China.
Arthur is an active member of China Democratic and Nation Building Committee, a minority political party consists of elite businessmen and professionals in China.
Member, Shanghai Bar Association
Member, China Democratic and Nation Building Committee
2016 | Report on the Regulations for Adoption of Cloud in the Healthcare Sector (Contributor)| Asia Cloud Computing Association
2015 | “Ready for the Cloud: A Report on FSI Regulations Impacting Cloud in Asia Pacific Markets” (Contributor)| Asia Cloud Computing Association
2013 | “The Impact of Data Sovereignty on Cloud Computing in Asia” (Contributor)| Asia Cloud Computing Association
Acquisition of 100% Shares/Equity Interest of PharmAgra Labs, Inc. and PharmAgra Holding Company, LLC. by Zhejiang Jiuzhou Pharmaceutical Co., Ltd.’s Wholly-owned Subsidiary, Zhejiang Raybow Pharmaceu2019-12-31